These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 19259072
1. Cutaneous metastatic Crohn's disease responsive to infliximab. Petrolati A, Altavilla N, Cipolla R, Fenderico P, Forlini G, Nasoni S, Rossi Z. Am J Gastroenterol; 2009 Apr; 104(4):1058. PubMed ID: 19259072 [No Abstract] [Full Text] [Related]
2. [Perianal ulceration as a diagnostic pathway to Crohn's regional enteritis]. Weidner F, Hornstein OP. Z Haut Geschlechtskr; 1971 Dec 15; 46(24):831-7. PubMed ID: 4400564 [No Abstract] [Full Text] [Related]
5. The management of fistulizing oral Crohn's disease with infliximab. Staines KS, Green R, Felix DH. J Oral Pathol Med; 2007 Aug 15; 36(7):444-6. PubMed ID: 17617840 [Abstract] [Full Text] [Related]
6. Treatment of recurrent Crohn's uveitis with infliximab. Ally MR, Veerappan GR, Koff JM. Am J Gastroenterol; 2008 Aug 15; 103(8):2150-1. PubMed ID: 18796120 [No Abstract] [Full Text] [Related]
7. Infliximab for the treatment of hidradenitis suppurativa. Lebwohl B, Sapadin AN. J Am Acad Dermatol; 2003 Nov 15; 49(5 Suppl):S275-6. PubMed ID: 14576652 [Abstract] [Full Text] [Related]
8. Cutaneous penile and perianal Crohn's disease treated with a combination of medical and surgical interventions. Rajpara SM, Siddha SK, Ormerod AD, Kerr KM, Kolhe PS. Australas J Dermatol; 2008 Feb 15; 49(1):21-4. PubMed ID: 18186842 [Abstract] [Full Text] [Related]
9. Cutaneous Crohn's disease presenting as genital warts: successful treatment with adalimumab. Lestre S, Ramos J, João A, Serrão V. Eur J Dermatol; 2010 Feb 15; 20(4):504-5. PubMed ID: 20507839 [No Abstract] [Full Text] [Related]
10. What is the rate of loss of response to infliximab therapy in Crohn's disease? Chao J, Mulani P. Am J Gastroenterol; 2009 Sep 15; 104(9):2353-4; author reply 2354-5. PubMed ID: 19727093 [No Abstract] [Full Text] [Related]
11. Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease. Tursi A. Dig Liver Dis; 2006 Jun 15; 38(6):439-40. PubMed ID: 16563889 [No Abstract] [Full Text] [Related]
12. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease]. Monteagudo Sánchez B, Cabanillas M, Ortiz-Marin S, Gallego-Ojea JC. Gastroenterol Hepatol; 2009 Mar 15; 32(3):175-6. PubMed ID: 19233516 [No Abstract] [Full Text] [Related]
13. Palmoplantar pustulosis and acrodermatitis in a patient treated with infliximab for Crohn's sacroiliitis. Wermuth J, Kind F, Steuerwald M. Clin Gastroenterol Hepatol; 2009 Feb 15; 7(2):A28. PubMed ID: 19187898 [No Abstract] [Full Text] [Related]
15. Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize. Sandborn WJ. Gastroenterology; 2003 Apr 15; 124(4):1140-5. PubMed ID: 12671907 [No Abstract] [Full Text] [Related]
16. Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone. Kemmler N, Pfannschmidt N, Strohal R. Acta Derm Venereol; 2012 Jul 15; 92(4):406-7. PubMed ID: 22113308 [No Abstract] [Full Text] [Related]